Germany's Dermapharm Looks To Future With Arkopharma As 2022 Sales Rise
Dermapharm has high hopes for 2023 as its acquisition of Arkopharma means the firm is now the number-one and number-three player respectively in the French and Spanish supplements markets.
You may also be interested in...
Germany's Dermapharm will pay €450m to acquire herbal specialist Arkopharma to expand its footprint in Europe's consumer health market in countries such as France, Spain and Italy.
Advancing personalized consumer innovation in healthy aging is the goal of a new partnership between Bayer and biological age test development firm Hurdle.
Stada has struck a deal with CR Sanjiu for distribution and promotion of its cough and cold brands after identifying expansion in the Chinese market as a key strategic target.